By Daniel Sabet · Cannabis CFO & Financial Advisor, GreenGrowth CPAs | Published May 2026 | Cannabis Tax Planning
| Rescheduling Status | 280E Relief: Medical & Dual-License | 280E Status: Adult-Use Only | Est. Excess 280E Taxes Paid Industry-Wide Since 2018 |
| Final order signed April 22, 2026 | In effect now — full FY2026 | Still applies — Schedule I | ~$15B* |
Cannabis rescheduling 2026 is done, and for dispensary owners it changes everything about how 280E applies to your operation. On April 22, Acting Attorney General Todd Blanche signed a final order. It moved state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III. 280E no longer applies to qualifying medical operations as a result. If you hold a medical license, you have three things to do before June 22 — and if you hold an adult-use license, you have one. GreenGrowth CPAs has worked with cannabis operators nationally through every stage of this shift. The firm’s consistent message right now is straightforward: the decisions made in the next 52 days will determine how much of this relief operators actually capture — and the operators who wait are the ones who lose it.
Quick Answer
Has cannabis been rescheduled, and does it end 280E for dispensaries? Yes — cannabis rescheduling 2026 is final and in effect as of April 22. For state-licensed medical marijuana operators, 280E no longer applies, effective for the full 2026 tax year under the IRS transition rule. For adult-use only operators, recreational cannabis remains Schedule I. 280E applies in full until at minimum the June 29, 2026 DEA hearing. The single most urgent action for medical and dual-license operators: register with the DEA by June 22, 2026 to lock in protected operating status.
Has Cannabis Been Rescheduled Yet?
Yes — as of April 22, 2026, cannabis rescheduling 2026 is final for state-licensed medical marijuana operators and FDA-approved cannabis products. Acting AG Blanche signed the order using treaty-implementation authority under 21 U.S.C. §811(d)(1). This bypassed the stalled rulemaking that had spent two years mired in procedural disputes. The order published in the Federal Register on April 28, 2026 and took effect immediately. No further public comment. No waiting period. No pending decision. For medical operators, rescheduling has happened. The June 29, 2026 DEA hearing will determine broader rescheduling for adult-use operators.
280E Cannabis Schedule III — At a Glance
- What happened: On April 22, 2026, a DOJ/DEA final order moved state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III — immediately and without further rulemaking
- Who gets 280E relief now: State-licensed medical marijuana operators get full 280E relief effective April 22, 2026. Dual-license operators (medical + adult-use) get partial relief — the medical side is no longer subject to 280E, while the adult-use side remains Schedule I. The IRS has not yet issued formal guidance on the exact scope of that relief for dual-license operators — specifically how shared expenses, inventory, and labor must be allocated. GreenGrowth’s team is monitoring that guidance closely.
- IRS transition rule: Treasury and the IRS have signaled FY2026 is treated as a 280E-free year for qualifying medical activity for the full calendar year — not just from April 22 forward
- Retroactive relief: The DOJ order encourages Treasury to consider 280E relief for prior tax years — this is a suggestion, not a mandate, and the IRS has not yet issued formal guidance
- DEA registration deadline: Medical and dual-license operators must register with the DEA by June 22, 2026 to benefit from expedited review and protected operating status; portal is live at deadiversion.usdoj.gov; fee is $794/year
- Adult-use status: Recreational cannabis remains Schedule I; the June 29, 2026 DEA hearing will determine whether broader rescheduling follows, with a July 15 conclusion deadline
What the Cannabis Rescheduling 2026 Order Actually Does — and What It Doesn’t
The cannabis rescheduling 2026 final order is the first time in 55 years the federal government has formally acknowledged that marijuana has accepted medical value. That acknowledgement is embedded in the act of moving it to Schedule III — the classification that includes ketamine and anabolic steroids. It happened through a single signed order, not years of additional rulemaking.
Section 280E is a provision of the Internal Revenue Code that disallows all deductions and credits for businesses engaged in trafficking Schedule I or Schedule II controlled substances, effectively treating gross margin as taxable income. Schedule III sits outside that disallowance entirely. For state-licensed medical operators, the impact is direct. Rent, payroll, marketing, and professional services are now federally deductible — for the first time in the history of the legal cannabis industry.
However, the order is precise about what it covers and what it doesn’t. Any marijuana outside an FDA-approved drug product or a qualifying state medical license remains Schedule I. Adult-use recreational sales — the larger market in most states — are unaffected today.
The Dollar Difference — In Plain Terms
Take a medical dispensary with $3 million in revenue, $1 million in COGS, and $800,000 in operating expenses. Under 280E, it paid federal tax on $2 million. Under Schedule III, that same business pays tax on roughly $1.2 million. That gap can exceed $200,000 per year — without changing a single thing about how the business operates.
WHO THIS ARTICLE IS FOR
- You hold both a medical and adult-use license and need to understand how to split operations, allocate shared expenses, and document the separation before the IRS asks
- You hold a state medical marijuana license only and want to understand your 280E relief, the IRS transition rule, and whether prior-year amended returns make sense
- You operate adult-use only and want an honest read on where you stand today and what the June 29 DEA hearing means for your business
- Your CPA has not yet modelled your FY2026 federal tax position under the new Schedule III rules — for any license type
The June 22 DEA Registration Deadline — What You Need to Do
Medical and dual-license operators who file by June 22, 2026 receive two protections. First, expedited federal review within six months. Second, the right to keep operating under their state license while the DEA processes the application. Operators who miss this window can still register — but they lose protected continuity. That means potentially pausing operations while the federal application is pending. For a running dispensary, that risk alone makes June 22 the priority.
The registration fee is $794 per year, payable via PayPal at deadiversion.usdoj.gov — the only official DEA registration portal; do not use third-party services for the application itself. Retail dispensaries use DEA Form 224; manufacturers and distributors use Form 225. Vertically integrated operators must file separately for each activity type. The DEA registration scope cannot exceed the scope of the underlying state license. Confirm your state license is current before filing — a federal DEA registration automatically suspends if the underlying state license lapses.
BENCHMARK
June 22, 2026 The 60-day window for medical and dual-license operators to file DEA registration and lock in protected operating continuity. Miss this date and you lose the expedited review pathway and the right to keep operating under your state license while the federal application is pending.
What the IRS Transition Rule Means for Your Cannabis Rescheduling 2026 Tax Return
- Full-year treatment: FY2026 is treated as 280E-free for qualifying medical activity for the entire calendar year — not just from April 22 forward
- Dual-license allocation: The IRS expects clear apportionment of expenses between medical and adult-use segments — with documentation built now, not reconstructed at audit
- Retroactive years: The IRS has not yet issued formal guidance; filing amended returns claiming prior-year relief ahead of that guidance carries meaningful audit risk
The Dual-License Problem Most Operators Aren’t Thinking About
Many operators hold both a medical cannabis license and an adult-use retail license — often in the same facility, sharing the same staff, inventory system, and lease. Until April 22, there was no federal tax reason to separate them. That changes immediately. This is also the area of cannabis rescheduling 2026 that GreenGrowth’s team fields the most questions about right now.
Why Commingled Books Create Double Exposure
Running both activities through the same entity with commingled books creates two risks at once. It can cost you the 280E relief on the medical side. It also creates audit exposure on the adult-use side. The operator carries the entire burden of proof. Shared costs — occupancy, labor, utilities, management fees — must be allocated between medical and adult-use operations. That allocation is the most consequential accounting decision a dual-license operator makes this year. GreenGrowth’s team builds these allocation structures for clients now, before IRS guidance narrows the available approaches.
CLIENT EXAMPLE
~$380,000 Illustrative annual federal tax reduction modelled for a dual-license operator following the April 22 order By designing a defensible expense allocation methodology separating medical and adult-use activity — and documenting it ahead of IRS guidance — an operator in this position may capture full medical-side 280E relief for FY2026 without restructuring the underlying business. Operator size, license type, and expense structure affect results.
When Will Cannabis Be Rescheduled for Adult-Use?
This is the question every recreational dispensary owner asks right now. The honest answer is June 29, 2026 — that is when the DEA administrative hearing begins to consider whether all marijuana, including adult-use recreational cannabis, moves from Schedule I to Schedule III as part of cannabis rescheduling 2026. The hearing must conclude by July 15. A favorable outcome would extend 280E relief to every state-licensed cannabis operator in the country. However, the outcome is not guaranteed. The hearing could produce full rescheduling, a narrower ruling, or no change. Even a positive ruling requires further IRS guidance before adult-use operators could safely take deductions.
The most valuable thing an adult-use operator can do right now is not wait and see. Model what your business looks like without 280E. Know your effective tax rate, your cash position, and what accounting changes maximise the benefit. Operators who complete that work will be ready to move within days of a ruling. Operators who start planning after the announcement will be months behind — and in a market moving this fast, that lag has a real dollar cost.
Cannabis Rescheduling 2026: The Relief Is Real — So Is the Risk of Getting It Wrong
The April 2026 order is historic, and GreenGrowth’s team says that plainly. However the gap between what the headlines say and what operators can actually do today is significant. Closing that gap requires specific action, not general optimism.
The Retroactive Question — What the DOJ Order Actually Says
The DOJ order encourages Treasury to consider relief for prior tax years under medical licenses. That single sentence has generated enormous excitement — and it is an encouragement, not a directive. The IRS has not yet issued formal guidance on retroactive treatment. Filing amended returns ahead of that guidance carries real audit risk. GreenGrowth’s team does not recommend that position without a formal legal opinion and you must have a documented allocation methodology in place first.
THE CONVERSATION WORTH HAVING
Ask your current CPA three questions: “Have you modelled our FY2026 federal tax return under the new Schedule III rules? Have you built an expense allocation methodology for our medical versus adult-use activity? And have you assessed our position on prior-year amended returns?” If the answer to any of those is no, your firm is not receiving cannabis-specialised tax counsel — and the decisions made in the next 90 days will either capture or permanently forfeit significant tax relief.
Request a Free 280E Tax Impact Analysis →
Key Takeaways
- Cannabis rescheduling 2026 is final — the April 22 order is signed and in effect, covering the full 2026 tax year for qualifying medical and dual-license operators
- Medical operators can now deduct ordinary business expenses — rent, payroll, marketing, professional services — for qualifying medical activity at the federal level for the first time
- The DEA registration deadline is June 22, 2026 — register within this window for expedited review and protected operating continuity; $794/year at deadiversion.usdoj.gov
- Dual-license operators must separate medical and adult-use accounting now — commingling books risks losing medical-side relief and creating adult-use audit exposure at the same time
- Adult-use cannabis remains Schedule I and 280E applies in full — the June 29 DEA hearing is the next major development for cannabis rescheduling 2026, with a hard July 15 conclusion deadline
Frequently Asked Questions — Cannabis Rescheduling 2026 and 280E
Has cannabis been rescheduled yet? Yes — cannabis rescheduling 2026 is final for state-licensed medical marijuana operators and FDA-approved cannabis products. The order took effect April 22, 2026 and published in the Federal Register on April 28. It is not pending and not subject to further public comment. Broader rescheduling covering adult-use recreational cannabis is subject to a separate DEA hearing beginning June 29, 2026, with a July 15 deadline to conclude.
When will cannabis be rescheduled for adult-use? The DEA administrative hearing beginning June 29, 2026 is the formal proceeding that will determine whether adult-use recreational cannabis follows medical into Schedule III under cannabis rescheduling 2026. That hearing must conclude by July 15. A favorable outcome is possible but not certain — and even a positive ruling requires further IRS guidance before adult-use operators could safely claim 280E deductions. GreenGrowth’s team will advise clients immediately upon any ruling.
Does cannabis rescheduling 2026 end 280E for my dispensary? For state-licensed medical marijuana operators, yes — 280E no longer applies to qualifying medical activity, effective for the full 2026 tax year. For adult-use only operators, no — 280E applies in full today. For dual-license operators, partial relief applies to the medical side only. The IRS has not yet issued formal guidance on how operators must allocate activity between the two sides.
Should I file amended returns for prior years to claim retroactive 280E relief? Proceed carefully. The DOJ order encourages Treasury to consider retroactive relief — but that is an encouragement, not a directive. The IRS has not yet issued formal guidance on retroactive treatment. Filing amended returns ahead of that guidance carries meaningful audit risk. GreenGrowth’s team does not recommend this position without a formal legal opinion and a documented allocation methodology already in place.
What happens if I miss the June 22 DEA registration deadline? You can still register after June 22, but you lose the expedited review pathway and the protected continuity status that allows you to keep operating under your state license while the federal application is pending. For most operating dispensaries that risk alone makes filing before the deadline the clear priority — the $794 fee and the time to complete a seven-section application are modest compared to the downside of losing protected status.
Find Out Exactly Where Your Dispensary Stands Under Cannabis Rescheduling 2026
GreenGrowth CPAs offers a dedicated 280E Tax Impact Analysis for operators navigating cannabis rescheduling 2026 — a structured review that maps your license type to the current order, models your FY2026 federal tax position, identifies your DEA registration obligations, and assesses your exposure on prior-year amended returns.
Request a 280E Tax Planning Review → Learn About Our Cannabis Tax Services →
GreenGrowth CPAs · Cannabis Tax Planning Team
